About Joslin | Patient Care | Supporting Joslin
The purpose of this study is to better understand the effect of exercise training on your adipose (fat) tissue.
The purpose of this study is to demonstrate whether,
in addition to standard of care (SoC), finerenone is superior to placebo in
delaying the progression of kidney disease.
The purpose of this study is to demonstrate whether finerenone
is superior to placebo in delaying the time to first occurrence of cardiovascular mortality in subjects with Type 2 Diabetes Mellitus and clinical
diagnosis of diabetic kidney disease.
The purpose of this study is to examine the mechanisms through with genetic factors may predispose people with diabetes to cardiovascular (heart) disease.
The purpose of this study is to determine whether a man's metabolic health, including diabetes and body weight, can affect signals in his sperm which affect how genes are turned on or off.
This study is evaluating the accuracy of an investigational device (not FDA approved yet) called LabPatch Continuous Glucose Monitor by comparing it to a laboratory glucose analyser called YSI, and 2 commercial glucose meters.
This study uses an electronic dose-recording device to examine dosing in individuals on multiple daily insulin injections.
This study examines the effect that mobile health technology has on promoting lifestyle changes in adults with type 2 diabetes.
The purpose of this study is to compare the effects of low fat and full fat dairy products on blood sugar control in people with type 2 diabetes.
The purpose of this study is to look at the effects of the study
interventions in the DPP on the development of type 2 diabetes as well as
diabetes related health problems and cancer diagnosis over a longer period of
The purpose of this study is to understand the long-term effects of weight change on overall health in the cohort of the original Look AHEAD study.
The purpose of this study is to determine the effect of meal replacement shakes on blood sugar control in people who have type 2 diabetes and are overweight.
The purpose of this trial is to study effects of an investigational drug, called Semaglutide (not FDA approved yet) that may help control blood sugar levels.
The purpose of TODAY 2
Phase 2 is to find out if the drug treatment or lifestyle program participants received during the TODAY Study has any long- term effect on blood sugar
control or the medical complications of diabetes, like heart or kidney disease.